{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:45:15Z","timestamp":1792201515226,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mesenchymal stromal cells (MSCs) have been demonstrated to ameliorate allergic contact dermatitis (ACD), a typical T-cell-mediated disorder. However, the underlying mechanisms behind the MSC-based treatment for ACD have not yet been fully elucidated. The stanniocalcins (STCs) comprise a family of secreted glycoprotein hormones that act as important anti-inflammatory proteins. Here, we investigated the roles of STCs in MSC-mediated T-cell suppression and their potential role in the MSC-based treatment for ACD. Gene expression profiling revealed that STC2, but not STC1, was highly expressed in MSCs. STC2 knockdown in MSCs significantly impaired their effects in reducing TNF-\u03b1- and IFN-\u03b3-producing CD8<jats:sup>+<\/jats:sup>T cells. Importantly, silencing the STC2 expression in MSCs abated their therapeutic effect on contact hypersensitivity (CHS) in mice, mainly restoring the generation and infiltration of IFN-\u03b3-producing CD8<jats:sup>+<\/jats:sup>T cells (Tc1 cells). Mechanistically, STC2 co-localized with heme oxygenase 1 (HO-1) in MSCs, and contributed to MSC-mediated reduction of CD8<jats:sup>+<\/jats:sup>Tc1 cells via regulating HO-1 activity. Together, these findings newly identify STC2 as the first stanniocalcin responsible for mediating the immunomodulatory effects of MSCs on allogeneic T cells and STC2 contribute to MSC-based treatment for ACD mainly via reducing the CD8<jats:sup>+<\/jats:sup>Tc1 cells.<\/jats:p>","DOI":"10.1038\/s41419-018-0614-x","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T13:19:37Z","timestamp":1525958377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Stanniocalcin-2 contributes to mesenchymal stromal cells attenuating murine contact hypersensitivity mainly via reducing CD8+ Tc1 cells"],"prefix":"10.1038","volume":"9","author":[{"given":"Xiaoyong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy Peng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,10]]},"reference":[{"key":"614_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaad.2014.03.023","volume":"71","author":"LF Eichenfield","year":"2014","unstructured":"Eichenfield, L. F. et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J. Am. Acad. Dermatol. 71, 116\u2013132 (2014).","journal-title":"J. Am. Acad. Dermatol."},{"key":"614_CR2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1468-3083.2012.04635.x","volume":"26","author":"J Ring","year":"2012","unstructured":"Ring, J. et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J. Eur. Acad. Dermatol. Venereol. 26, 1045\u20131060 (2012).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"614_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000154934","volume":"94","author":"A Cavani","year":"2008","unstructured":"Cavani, A. Immune regulatory mechanisms in allergic contact dermatitis and contact sensitization. Chem. Immunol. Allergy 94, 93\u2013100 (2008).","journal-title":"Chem. Immunol. Allergy"},{"issue":"2 Pt 1","key":"614_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S0091-6749(99)70489-6","volume":"103","author":"RS Kalish","year":"1999","unstructured":"Kalish, R. S. & Askenase, P. W. Molecular mechanisms of CD8+ T cell-mediated delayed hypersensitivity: implications for allergies, asthma, and autoimmunity. J. Allergy Clin. Immunol. 103(2 Pt 1), 192\u2013199 (1999).","journal-title":"J. Allergy Clin. Immunol."},{"key":"614_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1046\/j.1523-1747.1998.00236.x","volume":"111","author":"A Bouloc","year":"1998","unstructured":"Bouloc, A., Cavani, A. & Katz, S. I. Contact hypersensitivity in MHC class II-deficient mice depends on CD8 T lymphocytes primed by immunostimulating Langerhans cells. J. Invest. Dermatol. 111, 44\u201349 (1998).","journal-title":"J. Invest. Dermatol."},{"key":"614_CR6","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1002\/eji.1830251103","volume":"25","author":"H Bour","year":"1995","unstructured":"Bour, H. et al. Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur. J. Immunol. 25, 3006\u20133010 (1995).","journal-title":"Eur. J. Immunol."},{"key":"614_CR7","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.0022-202X.2005.23567.x","volume":"124","author":"P Saint-Mezard","year":"2005","unstructured":"Saint-Mezard, P. et al. Deficient contact hypersensitivity reaction in CD4-\/- mice is because of impaired hapten-specific CD8+ T cell functions. J. Invest. Dermatol. 124, 562\u2013569 (2005).","journal-title":"J. Invest. Dermatol."},{"key":"614_CR8","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.jaci.2014.10.002","volume":"135","author":"G Tsuji","year":"2015","unstructured":"Tsuji, G., Okiyama, N., Villarroel, V. A. & Katz, S. I. Histone deacetylase 6 inhibition impairs effector CD8 T-cell functions during skin inflammation. J. Allergy Clin. Immunol. 135, 1228\u20131239 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"614_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315\u2013317 (2006).","journal-title":"Cytotherapy"},{"key":"614_CR10","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","volume":"110","author":"AJ Nauta","year":"2007","unstructured":"Nauta, A. J. & Fibbe, W. E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110, 3499\u20133506 (2007).","journal-title":"Blood"},{"key":"614_CR11","doi-asserted-by":"publisher","first-page":"394917","DOI":"10.1155\/2015\/394917","volume":"2015","author":"ME Castro-Manrreza","year":"2015","unstructured":"Castro-Manrreza, M. E. & Montesinos, J. J. Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications. J. Immunol. Res. 2015, 394917 (2015).","journal-title":"J. Immunol. Res."},{"key":"614_CR12","doi-asserted-by":"publisher","first-page":"6576","DOI":"10.1182\/blood-2009-02-203943","volume":"113","author":"GM Spaggiari","year":"2009","unstructured":"Spaggiari, G. M., Abdelrazik, H., Becchetti, F. & Moretta, L. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113, 6576\u20136583 (2009).","journal-title":"Blood"},{"key":"614_CR13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/stem.2401","volume":"35","author":"HS Kim","year":"2017","unstructured":"Kim, H. S. et al. Clinical trial of human umbilical cord blood-derived stem cells for the treatment of moderate-to-severe atopic dermatitis: phase I\/IIa studies. Stem Cells 35, 248\u2013255 (2017).","journal-title":"Stem Cells"},{"key":"614_CR14","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.ymthe.2017.04.004","volume":"25","author":"X Zhang","year":"2017","unstructured":"Zhang, X. et al. CXCR5-overexpressing mesenchymal stromal cells exhibit enhanced homing and can decrease contact hypersensitivity. Mol. Ther. 25, 1434\u20131447 (2017).","journal-title":"Mol. Ther."},{"key":"614_CR15","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/leu.2014.225","volume":"29","author":"Y Peng","year":"2015","unstructured":"Peng, Y. et al. Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10. Leukemia 29, 636\u2013646 (2015).","journal-title":"Leukemia"},{"key":"614_CR16","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.mce.2011.11.007","volume":"349","author":"BH Yeung","year":"2012","unstructured":"Yeung, B. H., Law, A. Y. & Wong, C. K. Evolution and roles of stanniocalcin. Mol. Cell. Endocrinol. 349, 272\u2013280 (2012).","journal-title":"Mol. Cell. Endocrinol."},{"key":"614_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/0394632015572745","volume":"28","author":"SJ Chu","year":"2015","unstructured":"Chu, S. J., Zhang, J., Zhang, R., Lu, W. W. & Zhu, J. S. Evolution and functions of stanniocalcins in cancer. Int. J. Immunopathol. Pharmacol. 28, 14\u201320 (2015).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"614_CR18","first-page":"1289","volume":"62","author":"T Bouras","year":"2002","unstructured":"Bouras, T. et al. Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res. 62, 1289\u20131295 (2002).","journal-title":"Cancer Res."},{"key":"614_CR19","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1158\/1078-0432.CCR-07-0224","volume":"13","author":"S Esseghir","year":"2007","unstructured":"Esseghir, S. et al. Identification of NTN4, TRA1, and STC2 as prognostic markers in breast cancer in a screen for signal sequence encoding proteins. Clin. Cancer Res. 13, 3164\u20133173 (2007).","journal-title":"Clin. Cancer Res."},{"key":"614_CR20","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1200\/JCO.2006.08.8583","volume":"25","author":"RJ Buckanovich","year":"2007","unstructured":"Buckanovich, R. J. et al. Tumor vascular proteins as biomarkers in ovarian cancer. J. Clin. Oncol. 25, 852\u2013861 (2007).","journal-title":"J. Clin. Oncol."},{"key":"614_CR21","doi-asserted-by":"publisher","first-page":"F248","DOI":"10.1152\/ajprenal.00260.2009","volume":"298","author":"D Sheikh-Hamad","year":"2010","unstructured":"Sheikh-Hamad, D. Mammalian stanniocalcin-1 activates mitochondrial antioxidant pathways: new paradigms for regulation of macrophages and endothelium. Am. J. Physiol.-Ren. 298, F248\u2013F254 (2010).","journal-title":"Am. J. Physiol.-Ren."},{"key":"614_CR22","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.2353\/ajpath.2009.080476","volume":"174","author":"LP Huang","year":"2009","unstructured":"Huang, L. P. et al. Anti-inflammatory and renal protective actions of stanniocalcin-1 in a model of anti-glomerular basement membrane glomerulonephritis. Am. J. Pathol. 174, 1368\u20131378 (2009).","journal-title":"Am. J. Pathol."},{"key":"614_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1371\/annotation\/c8b2e360-b78a-4c2f-a1a3-c53325f18211","volume":"8","author":"SJ Kim","year":"2013","unstructured":"Kim, S. J. et al. Stanniocalcin-1 protects retinal ganglion cells by inhibiting apoptosis and oxidative damage. PLoS ONE 8, 5 (2013).","journal-title":"PLoS ONE"},{"key":"614_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.freeradbiomed.2014.03.034","volume":"71","author":"SE Tang","year":"2014","unstructured":"Tang, S. E. et al. Stanniocalcin-1 ameliorates lipopolysaccharide-induced pulmonary oxidative stress, inflammation, and apoptosis in mice. Free Radic. Bio. Med. 71, 321\u2013331 (2014).","journal-title":"Free Radic. Bio. Med"},{"key":"614_CR25","doi-asserted-by":"publisher","first-page":"9456","DOI":"10.1128\/MCB.24.21.9456-9469.2004","volume":"24","author":"D Ito","year":"2004","unstructured":"Ito, D. et al. Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties. Mol. Cell. Biol. 24, 9456\u20139469 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"614_CR26","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1016\/j.peptides.2010.08.002","volume":"31","author":"JS Byun","year":"2010","unstructured":"Byun, J. S. et al. Neuroprotective effects of stanniocalcin 2 following kainic acid-induced hippocampal degeneration in ICR mice. Peptides 31, 2094\u20132099 (2010).","journal-title":"Peptides"},{"key":"614_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/stem.20080742","volume":"27","author":"GJ Block","year":"2009","unstructured":"Block, G. J. et al. Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. Stem Cells 27, 670\u2013681 (2009).","journal-title":"Stem Cells"},{"key":"614_CR28","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","volume":"99","author":"M Di Nicola","year":"2002","unstructured":"Di Nicola, M. et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 3838\u20133843 (2002).","journal-title":"Blood"},{"key":"614_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000023934","volume":"116","author":"A Moussavi","year":"1998","unstructured":"Moussavi, A., Dearman, R. J., Kimber, I. & Kemeny, D. M. Cytokine production by CD4+ and CD8+ T cells in mice following primary exposure to chemical allergens: evidence for functional differentiation of T lymphocytes in vivo. Int. Arch. Allergy Immunol. 116, 116\u2013123 (1998).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"614_CR30","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1046\/j.1365-2567.1996.d01-778.x","volume":"89","author":"RJ Dearman","year":"1996","unstructured":"Dearman, R. J., Moussavi, A., Kemeny, D. M. & Kimber, I. Contribution of CD4+ and CD8+ T lymphocyte subsets to the cytokine secretion patterns induced in mice during sensitization to contact and respiratory chemical allergens. Immunology 89, 502\u2013510 (1996).","journal-title":"Immunology"},{"key":"614_CR31","doi-asserted-by":"publisher","first-page":"6783","DOI":"10.4049\/jimmunol.165.12.6783","volume":"165","author":"BH Wang","year":"2000","unstructured":"Wang, B. H. et al. CD4(+) Th1 and CD8(+) type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J. Immunol. 165, 6783\u20136790 (2000).","journal-title":"J. Immunol."},{"key":"614_CR32","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbrc.2012.03.151","volume":"421","author":"J Jiang","year":"2012","unstructured":"Jiang, J., Westberg, J. A. & Andersson, L. C. Stanniocalcin 2, forms a complex with heme oxygenase 1, binds hemin and is a heat shock protein. Biochem. Bioph. Res. Co. 421, 274\u2013279 (2012).","journal-title":"Biochem. Bioph. Res. Co."},{"key":"614_CR33","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1182\/blood-2007-02-075481","volume":"110","author":"D Chabannes","year":"2007","unstructured":"Chabannes, D. et al. A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 110, 3691\u20133694 (2007).","journal-title":"Blood"},{"key":"614_CR34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ccell.2016.06.005","volume":"30","author":"S Di Biase","year":"2016","unstructured":"Di Biase, S. et al. Fasting-mimicking diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity. Cancer Cell 30, 136\u2013146 (2016).","journal-title":"Cancer Cell"},{"key":"614_CR35","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/cmi.2014.118","volume":"12","author":"QL Liu","year":"2015","unstructured":"Liu, Q. L. et al. Human mesenchymal stromal cells enhance the immunomodulatory function of CD8(+) CD28(-) regulatory T cells. Cell. Mol. Immunol. 12, 708\u2013718 (2015).","journal-title":"Cell. Mol. Immunol."},{"key":"614_CR36","doi-asserted-by":"publisher","first-page":"F356","DOI":"10.1152\/ajprenal.00138.2003","volume":"286","author":"J Kanellis","year":"2004","unstructured":"Kanellis, J. et al. Stanniocalcin-1, an inhibitor of macrophage chemotaxis and chemokinesis. Am. J. Physiol.-Ren. 286, F356\u2013F362 (2004).","journal-title":"Am. J. Physiol.-Ren."},{"key":"614_CR37","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/mt.2014.217","volume":"23","author":"M Ono","year":"2015","unstructured":"Ono, M. et al. Mesenchymal stem cells correct inappropriate epithelial\u2212mesenchyme relation in pulmonary fibrosis using Stanniocalcin-1. Mol. Ther. 23, 549\u2013560 (2015).","journal-title":"Mol. Ther."},{"key":"614_CR38","doi-asserted-by":"publisher","first-page":"702","DOI":"10.5483\/BMBRep.2015.48.12.158","volume":"48","author":"PH Kim","year":"2015","unstructured":"Kim, P. H., Na, S. S., Lee, B., Kim, J. H. & Cho, J. Y. Stanniocalcin 2 enhances mesenchymal stem cell survival by suppressing oxidative stress. Bmb Rep. 48, 702\u2013707 (2015).","journal-title":"Bmb Rep."},{"key":"614_CR39","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.4049\/jimmunol.145.11.3706","volume":"145","author":"RS Kalish","year":"1990","unstructured":"Kalish, R. S. & Johnson, K. L. Enrichment and function of urushiol (poison ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to urushiol. J. Immunol. 145, 3706\u20133713 (1990).","journal-title":"J. Immunol."},{"key":"614_CR40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1152\/physrev.00011.2005","volume":"86","author":"SW Ryter","year":"2006","unstructured":"Ryter, S. W., Alam, J. & Choi, A. M. K. Heme oxygenase-1\/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86, 583\u2013650 (2006).","journal-title":"Physiol. Rev."},{"key":"614_CR41","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1182\/blood-2010-12-324038","volume":"117","author":"D Mougiakakos","year":"2011","unstructured":"Mougiakakos, D. et al. The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood 117, 4826\u20134835 (2011).","journal-title":"Blood"},{"key":"614_CR42","doi-asserted-by":"publisher","first-page":"34612","DOI":"10.1074\/jbc.M113.494369","volume":"288","author":"YJ Zhang","year":"2013","unstructured":"Zhang, Y. J., Zhang, L. Y., Wu, J. H., Di, C. X. & Xia, Z. W. Heme oxygenase-1 exerts a protective role in ovalbumin-induced neutrophilic airway inflammation by inhibiting Th17 cell-mediated immune response. J. Biol. Chem. 288, 34612\u201334626 (2013).","journal-title":"J. Biol. Chem."},{"key":"614_CR43","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/cmi.2015.02","volume":"13","author":"MJ Uddin","year":"2016","unstructured":"Uddin, M. J. et al. IRG1 induced by heme oxygenase-1\/carbon monoxide inhibits LPS-mediated sepsis and pro-inflammatory cytokine production. Cell. Mol. Immunol. 13, 170\u2013179 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"614_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/sji.12189","volume":"80","author":"I Nikolic","year":"2014","unstructured":"Nikolic, I., Vujicic, M., Stojanovic, I., Stosic-Grujicic, S. & Saksida, T. Carbon monoxide-releasing molecule-A1 inhibits Th1\/Th17 and stimulates Th2 differentiation in vitro. Scand. J. Immunol. 80, 95\u2013100 (2014).","journal-title":"Scand. J. Immunol."},{"key":"614_CR45","doi-asserted-by":"publisher","first-page":"613249","DOI":"10.1155\/2015\/613249","volume":"2015","author":"MJ Uddin","year":"2015","unstructured":"Uddin, M. J. et al. Carbon monoxide inhibits tenascin-C mediated inflammation via IL-10 expression in a septic mouse model. Mediat. Inflamm. 2015, 613249 (2015).","journal-title":"Mediat. Inflamm."},{"key":"614_CR46","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.4049\/jimmunol.172.8.4744","volume":"172","author":"HO Pae","year":"2004","unstructured":"Pae, H. O. et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J. Immunol. 172, 4744\u20134751 (2004).","journal-title":"J. Immunol."},{"key":"614_CR47","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/1556-4029.12130","volume":"58","author":"V Varlet","year":"2013","unstructured":"Varlet, V., De Croutte, E. L., Augsburger, M. & Mangin, P. A new approach for the carbon monoxide (CO) exposure diagnosis: measurement of total CO in human blood versus carboxyhemoglobin (HbCO). J. Forensic Sci. 58, 1041\u20131046 (2013).","journal-title":"J. Forensic Sci."},{"key":"614_CR48","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/clinchem\/37.8.1442","volume":"37","author":"AH Chalmers","year":"1991","unstructured":"Chalmers, A. H. Simple, sensitive measurement of carbon monoxide in plasma. Clin. Chem. 37, 1442\u20131445 (1991).","journal-title":"Clin. Chem."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0614-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0614-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0614-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T14:59:37Z","timestamp":1693666777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0614-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,10]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5]]}},"alternative-id":["614"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0614-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,10]]},"assertion":[{"value":"22 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"548"}}